Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients
- PMID: 16965625
- PMCID: PMC1584240
- DOI: 10.1186/1471-2334-6-137
Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients
Abstract
Background: Endocarditis is a common complication in Staphylococcus aureus bacteremia (SAB). We compared risk factors, clinical manifestations, and outcome in a large, prospective cohort of patients with S. aureus endocarditis in injection drug users (IDUs) and in nonaddicts.
Methods: Four hundred and thirty consecutive adult patients with SAB were prospectively followed up for 3 months. Definite or possible endocarditis by modified Duke criteria was found in 74 patients: 20 patients were IDUs and 54 nonaddicts.
Results: Endocarditis was more common in SAB among drug abusers (46%) than in nonaddicts (14%) (odds ratio [OR], 5.12; 95% confidence interval [CI], 2.65-9.91; P < 0.001). IDUs were significantly younger (27 +/- 15 vs 65 +/- 15 years, P < 0.001), had less ultimately or rapidly fatal underlying diseases (0% vs 37%, P < 0.001) or predisposing heart diseases (20% vs 50%, P = 0.03), and their SAB was more often community-acquired (95% vs 39%, P < 0.001). Right-sided endocarditis was observed in 60% of IDUs whereas 93% of nonaddicts had left-sided involvement (P < 0.001). An extracardiac deep infection was found in 85% of IDUs and in 89% of nonaddicts (P = 0.70). Arterial thromboembolic events and severe sepsis were also equally common in both groups. There was no difference in mortality between the groups at 7 days, but at 3 months it was lower among IDUs (10%) compared with nonaddicts (39%) (OR, 5.73; 95% CI, 1.20-27.25; P = 0.02).
Conclusion: S. aureus endocarditis in IDUs was associated with as high complication rates including extracardiac deep infections, thromboembolic events, or severe sepsis as in nonaddicts. Injection drug abuse in accordance with younger age and lack of underlying diseases were associated with lower mortality, but after adjusting by age and underlying diseases injection drug abuse was not significantly associated with mortality.
Similar articles
-
Methicillin-sensitive Staphylococcus aureus bacteraemia and endocarditis among injection drug users and nonaddicts: host factors, microbiological and serological characteristics.J Infect. 2008 Apr;56(4):249-56. doi: 10.1016/j.jinf.2008.01.009. Epub 2008 Mar 7. J Infect. 2008. PMID: 18314197 Clinical Trial.
-
Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.J Hosp Infect. 2011 Jun;78(2):102-7. doi: 10.1016/j.jhin.2011.03.010. Epub 2011 Apr 20. J Hosp Infect. 2011. PMID: 21511366
-
[Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].Enferm Infecc Microbiol Clin. 1993 May;11(5):235-40. Enferm Infecc Microbiol Clin. 1993. PMID: 8324018 Clinical Trial. Spanish.
-
Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with Panton-Valentine leukocidin-negative strains.Scand J Infect Dis. 2007;39(4):299-302. doi: 10.1080/00365540601003803. Scand J Infect Dis. 2007. PMID: 17454892 Review.
-
[Staphylococcus aureus sepsis in hospitalized non neutropenic patients: retrospective clinical and microbiological analysis].Ann Ital Med Int. 2002 Jul-Sep;17(3):166-72. Ann Ital Med Int. 2002. PMID: 12402664 Review. Italian.
Cited by
-
Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland.BMC Microbiol. 2007 Jul 2;7:62. doi: 10.1186/1471-2180-7-62. BMC Microbiol. 2007. PMID: 17605795 Free PMC article.
-
Association between route of illicit drug administration and hospitalizations for infective endocarditis.SAGE Open Med. 2017 Dec 15;5:2050312117740987. doi: 10.1177/2050312117740987. eCollection 2017. SAGE Open Med. 2017. PMID: 29276587 Free PMC article.
-
Risk factors of mid-term mortality of patients with infective endocarditis.Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1355-60. doi: 10.1007/s10096-010-1006-z. Epub 2010 Jul 17. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20640585
-
Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy.J Antimicrob Chemother. 2009 May;63(5):1034-42. doi: 10.1093/jac/dkp051. Epub 2009 Mar 5. J Antimicrob Chemother. 2009. PMID: 19264792 Free PMC article. Clinical Trial.
-
Intravenous drug abuse and tricuspid valve endocarditis: Growing trends in the Middle East Gulf region.World J Cardiol. 2013 Nov 26;5(11):397-403. doi: 10.4330/wjc.v5.i11.397. World J Cardiol. 2013. PMID: 24829628 Free PMC article.
References
-
- Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VGJ. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41:507–514. doi: 10.1086/431979. - DOI - PubMed
-
- Fowler VGJ, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS. Staphylococcus aureus endocarditis: a consequence of medical progress. Jama. 2005;293:3012–3021. doi: 10.1001/jama.293.24.3012. - DOI - PubMed
-
- Hedstrom SA, Christensson B. Staphylococcus aureus septicaemia and endocarditis at the University Hospital in Lund 1976-1980. Scand J Infect Dis Suppl. 1983;41:38–48. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical